本页面由Tiger Trade Technology Pte. Ltd.提供服务

Redhill Biopharma Ltd

0.7845
-0.0285-3.51%
盘后0.79570.0112+1.43%19:53 EDT
成交量:1.28万
成交额:1.04万
市值:399.49万
市盈率:-0.13
高:0.8544
开:0.8365
低:0.7835
收:0.8130
52周最高:3.31
52周最低:0.7101
股本:509.23万
流通股本:332.99万
量比:0.52
换手率:0.39%
股息:- -
股息率:- -
每股收益(TTM):-6.0249
每股收益(LYR):-6.7096
净资产收益率:-1708.61%
总资产收益率:-25.32%
市净率:-0.91
市盈率(LYR):-0.12

数据加载中...

2020/11/12

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/08/13

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/08/13

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/05/27

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/05/05

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/26

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/04

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/04

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]